Tags: COVID | infection | reinfection | vaccine | omicron | alpha | delta

Prior COVID-19 Infection Proves Less Effective Against Omicron

Omicron COVID-19 variant
(Dreamstime)

By    |   Friday, 07 January 2022 04:24 PM EST

New research reveals that prior infection from COVID-19 is not as protective when it comes to symptomatic omicron reinfections. This news comes as the highly contagious variant sweeps the nation. A new study conducted by researchers in Qatar, which has not been peer reviewed yet, found that you cannot count on previous infection caused by other coronavirus variants to protect you from getting COVID-19 again.

Prior infections were 90% effective against symptomatic infections for the alpha variant, 92% effective against delta, and only 56% effective against omicron.

According to Axios, initial studies revealed that coronavirus vaccines, particularly without a booster shot, are also much less effective against omicron than other variants, although they do seem to prevent serious disease. This has been verified by another study conducted by researchers at the Ragon Institute at Massachusetts General Hospital, MIT, and Harvard.

“Even if antibodies can’t keep us from getting infected with omicron, other aspects of the immune response may keep us from becoming very sick,” said Alejandro Balazs, of the Ragon Institute. But new data suggests that vaccine effectiveness does wane over time, according to USA Today. Balazs’ study also found that the best antibody response came from getting two doses of the mRNA vaccines from Moderna and Pfizer, followed by a booster.

Even getting infected by omicron after being vaccinated wasn’t anywhere near as effective as getting the booster. The booster created “substantially higher” antibodies than vaccination followed by infection, said the authors, who published their findings in the journal Cell. The mRNA booster was also effective for those who received one dose of the Johnson & Johnson shot.

The two studies emphasize the importance of getting boosters to evade omicron’s remarkable ability to evade immune protection either from vaccines or infection, which goes a long way to explain its explosive growth rate, says Axios.

Lynn C. Allison

Lynn C. Allison, a Newsmax health reporter, is an award-winning medical journalist and author of more than 30 self-help books.

© 2025 NewsmaxHealth. All rights reserved.


Health-News
New research reveals that prior infection from COVID-19 is not as protective when it comes to symptomatic omicron reinfections. This news comes as the highly contagious variant sweeps the nation. A new study conducted by researchers in Qatar, which has not been peer...
COVID, infection, reinfection, vaccine, omicron, alpha, delta
308
2022-24-07
Friday, 07 January 2022 04:24 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved